Back to trial detailsIntake questionnaire
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Applying to Synergy Group Medical · Houston, Texas
Answer a few short questions to share with the research team.
0 of 4 answered